Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 25

Sort by

Sort Order Select

Journal Articles

Whole-Genome Sequencing of 95 Japanese Patients with Pediatric Acute Myeloid Leukemia

Kaito Mimura, Norio Shiba, Ai Okada, Kenichi Chiba, Kentaro Watanabe, Takao Deguchi, Kentaro Ohki, Kotoe Katayama, Seiya Imoto, Akiko M Saito, Yasuhiro Okamoto, Souichi Adachi, Daisuke Tomizawa, Takashi Taga, Yuichi Shiraishi, Hiroshi Moritake, Motohiro Kato, Kenichi Yoshida

Blood (2024) 144 (Supplement 1): 5720.

https://doi.org/10.1182/blood-2024-200476

Published: 2024

Journal Articles

Prognostic Factors for T-Cell Acute Lymphoblastic Leukemia in Children and Young Adults: ALL-T11 Study Conducted By Japan Children's Cancer Group and Japan Adult Leukemia Study Group

Blood (2024) 144 (Supplement 1): 1426.

https://doi.org/10.1182/blood-2024-199500

Published: 2024

Journal Articles

A Nationwide Clinical Trial ALL-B12: An Optimized Therapy for Pediatric B-Precursor Acute Lymphoblastic Leukemia with Excellent Overall Survival and Minimal Non-Relapse Mortality: A Report from the Japan Children's Cancer Group

Blood (2023) 142 (Supplement 1): 519.

https://doi.org/10.1182/blood-2023-182464

Published: 2023

Journal Articles

Higher CD34+ Cell Doses Correlate with Reduced Incidence of Relapse and Better Event-Free Survival after KIR-Ligand Mismatch Cord Blood Transplantation for Childhood Acute Myeloid Leukemia

Hisashi Ishida, Yuta Kawahara, Daisuke Tomizawa, Yasuhiro Okamoto, Yuko Cho, Katsuyoshi Koh, Yuhki Koga, Asahito Hama, Maho Sato, Kiminori Terui, Naoyuki Miyagawa, Akihiro Watanabe, Junko Takita, Koji Kato, Kimikazu Matsumoto, Moeko Hino, Ken Tabuchi, Hirotoshi Sakaguchi

Blood (2023) 142 (Supplement 1): 2843.

https://doi.org/10.1182/blood-2023-174310

Published: 2023

Journal Articles

Outcome of Newly Diagnosed Children and Adolescents with Localized Lymphoblastic Lymphoma Treated on JPLSG-LLB-NHL03 Trial: A Report from the Japan Children's Cancer Group

Masahiro Sekimizu, Tomoyuki Watanabe, Tetsuya Mori, Ryoji Kobayashi, Atsuko Nakazawa, Akiko M Saito, Tetsuya Takimoto, Masahito Tsurusawa, Keizo Horibe, Yasuhiro Okamoto, Shosuke Sunami

Blood (2023) 142 (Supplement 1): 3012.

https://doi.org/10.1182/blood-2023-178421

Published: 2023

Journal Articles

Risk Stratified Therapy with Nelarabine and Intensified Administration of L-Asparaginase for Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia in Adolescents and Young Adults (JPLSG T-11/JALSG T-ALL-211-U): An Intergroup Phase 2 Study

Blood (2022) 140 (Supplement 1): 124–126.

https://doi.org/10.1182/blood-2022-156613

Published: 2022

Journal Articles

Prognostic Factors in Children with Acute Myeloid Leukemia Receiving the First Hematopoietic Stem Cell Transplantation in Second Remission

Blood (2022) 140 (Supplement 1): 6075–6076.

https://doi.org/10.1182/blood-2022-158712

Published: 2022

Journal Articles

Impact of Nelarabine, Intensive L-Asparaginase, and Protracted Intrathecal Therapy on Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia: Results from the Japanese Pediatric Leukemia/Lymphoma Study Group and the Japan Adult Leukemia Study Group

Blood (2021) 138 (Supplement 1): 3393.

https://doi.org/10.1182/blood-2021-149110

Published: 2021

Journal Articles

Clonal Evolution Pattern and Prognostic Significance of Clonal Architecture in KMT2A -Rearranged Acute Myeloid Leukemia

Blood (2021) 138 (Supplement 1): 2358.

https://doi.org/10.1182/blood-2021-146699

Published: 2021

Journal Articles

Hematopoietic Stem-Cell Transplantation in Children with Refractory Acute Myeloid Leukemia

Yasuhiro Okamoto, MD, Kazuko Kudo, MD PhD, Ken Tabuchi, MD, Daisuke Tomizawa, MD PhD, Takashi Taga, MD PhD, Hiroaki Goto, MD, Hiromasa Yabe, MD, PhD, Yozo Nakazawa, MD, PhD, Katsuyoshi Koh, MD, Kazuhiro Ikegame, MD PhD, Nao Yoshida, MD PhD, Naoyuki Uchida, MD PhD, Kenichiro Watanabe, MD PhD, Yuuki Koga, MD PhD, Masami Inoue, MD, Koji Kato, MD PhD, Yoshiko Atsuta, MD PhD, Hiroyuki Ishida, MD, PhD

Blood (2018) 132 (Supplement 1): 4632.

https://doi.org/10.1182/blood-2018-99-111322

Published: 2018

Journal Articles

Hematopoietic Stem Cell Transplantation in Children with Refractory Acute Lymphoblastic Leukemia

Yasuhiro Okamoto, MD, Yozo Nakazawa, MD, PhD, Masami Inoue, MD, Kenichiro Watanabe, MD PhD, Hiroaki Goto, MD, Nao Yoshida, MD PhD, Maiko Noguchi, MD, Atsushi Kikuta, MD, Koji Kato, MD PhD, Yoshiko Hashii, MD PhD, Yoshiko Atsuta, MD PhD, Motohiro Kato, MD PhD

Blood (2018) 132 (Supplement 1): 2173.

https://doi.org/10.1182/blood-2018-99-111301

Published: 2018

Journal Articles

Nationwide Survey of Pediatric Hypodiploid Acute Lymphoblastic Leukemia in Japan

Blood (2017) 130 (Supplement 1): 5121.

https://doi.org/10.1182/blood.V130.Suppl_1.5121.5121

Published: 2017

Journal Articles

Augmented Consolidation Therapy Based on Minimal Residual Disease (MRD) and Analysis of the Measurement of Sequential MRD in Childhood Acute Lymphoblastic Leukemia : Children's Cancer and Leukemia Study Group of JAPAN (CCLSG), Cclsg ALL 2004 Protocol Study

Blood (2015) 126 (23): 3724.

https://doi.org/10.1182/blood.V126.23.3724.3724

Published: 2015

Journal Articles

Comparison of transplantation with reduced and myeloablative conditioning for children with acute lymphoblastic leukemia

Koji Kato, Motohiro Kato, Daiichiro Hasegawa, Hirohide Kawasaki, Hiroyuki Ishida, Yasuhiro Okamoto, Katsuyoshi Koh, Masami Inoue, Jiro Inagaki, Keisuke Kato, Hisashi Sakamaki, Hiromasa Yabe, Keisei Kawa, Ritsuro Suzuki, Yoshiko Atsuta

Blood (2015) 125 (8): 1352–1354.

https://doi.org/10.1182/blood-2014-10-604702

Published: 2015

Journal Articles

Comparison of Stem Cell Transplantation with Reduced Intensity Conditioning (RIC) and Myeloablative Conditioning (MAC) for Children with Acute Lymphoblastic Leukemia

Koji Kato, MDPhD, Motohiro Kato, MD PhD, Daiichiro Hasegawa, MD, Hirohide Kawasaki, MD, Hiroyuki Ishida, MD PhD, Yasuhiro Okamoto, MD, Katsuyoshi Koh, MD PhD, Masami Inoue, MD, Jiro Inagaki, MD, Keisuke Kato, MD, Hisashi Sakamaki, MDPhD, Hiromasa Yabe, MD PhD, Keisei Kawa, MD PhD, Ritsuro Suzuki, MD PhD, Yoshiko Atsuta, MDPhD

Blood (2014) 124 (21): 544.

https://doi.org/10.1182/blood.V124.21.544.544

Published: 2014

Journal Articles

Mechanisms and Prevention of Fatal Cardiotoxicity Following High-Dose Cyclophosphamide Therapy

Takuro Nishikawa, MD PhD, Emiko Miyahara, PhD, Koichiro Kurauchi, MD, Erika Watanabe, PhC, Yasuhiro Okamoto, MD, Yoshifumi Kawano, MD PhD

Blood (2014) 124 (21): 5789.

https://doi.org/10.1182/blood.V124.21.5789.5789

Published: 2014

Journal Articles

Comparison Of Intravenous With Oral Busulfan In Allogeneic Hematopoietic Stem Cell Transplantation With Myeloablative Conditioning Regimens For Pediatric Acute Leukemia

Motohiro Kato, Yoshiyuki Takahashi, MD, PhD, Daisuke Tomizawa, MD, PhD, Yasuhiro Okamoto, MD, Jiro Inagaki, MD, PhD, Katsuyoshi Koh, MD, Atsushi Ogawa, MD, Keiko Okada, Yuko Cho, MD, PhD, Junko Takita, MD, Hiroaki Goto, MD., PhD, Hisashi Sakamaki, MD, PhD, Hiromasa Yabe, Keisei Kawa, MD, Ritsuro Suzuki, MD, Kazuko Kudo, MD, PhD, Koji Kato, MD, PhD

Blood (2013) 122 (21): 3397.

https://doi.org/10.1182/blood.V122.21.3397.3397

Published: 2013

Journal Articles

Myeloperoxidase-Derived Halogenative Stress, a Possible Cause of Benzene Leukemogenesis

Takuro Nishikawa, MD, Emiko Miyahara, Miss, Masahisa Horiuchi, MD, Kimiko Izumo, Miss, Yasuhiro Okamoto, MD, Yoshichika Kawai, PhD, Yoshifumi Kawano, MD, PhD, Toru Takeuchi, MD, PhD

Blood (2011) 118 (21): 4404.

https://doi.org/10.1182/blood.V118.21.4404.4404

Published: 2011

Journal Articles

Combined Analysis of Treatments for Pediatric T-ALL in KYCCSG Protocols, ALL-96 and ALL-02.

Yasuhiro Okamoto, MD, Yoshihisa Nagatoshi, MD, Akinobu Matsuzaki, MD, Aiko Suminoe, MD, Hideki Nakayama, MD, PhD, Noriko Hotta, MD, Shuuichi Ohzono, MD, PhD, Kyoko Fujita, MD, Kiyoshi Kawakami, MD, Fumio Yanai, MD, Hiroshi Moritake, MD, PhD, Jiro Inagaki, MD, Yoshifumi Kawano, MD, PhD, Jun Okamura, MD

Blood (2009) 114 (22): 4102.

https://doi.org/10.1182/blood.V114.22.4102.4102

Published: 2009

Journal Articles

Direct Interaction of G-CSF-Stimulated-Neutrophils and HUVECs Are Necessary for Production of IL-8 in Endothelial Cells.

Yasuhiro Okamoto, MD, Tsutomu Watanabe, MD, Toshihiro Onishi, MD, Hiroyoshi Watanabe, MD, Yuni Yamaki, MD, Yuichi Kodama, MD, Takuro Nishikawa, MD, Takayuki Tanabe, MD, Yuichi Shinkoda, MD, Yoshifumi Kawano, MD

Blood (2007) 110 (11): 4038.

https://doi.org/10.1182/blood.V110.11.4038.4038

Published: 2007

NARROW

Whole-Genome Sequencing of 95 Japanese Patients with Pediatric Acute Myeloid Leukemia

Prognostic Factors for T-Cell Acute Lymphoblastic Leukemia in Children and Young Adults: ALL-T11 Study Conducted By Japan Children's Cancer Group and Japan Adult Leukemia Study Group

A Nationwide Clinical Trial ALL-B12: An Optimized Therapy for Pediatric B-Precursor Acute Lymphoblastic Leukemia with Excellent Overall Survival and Minimal Non-Relapse Mortality: A Report from the Japan Children's Cancer Group

Higher CD34+ Cell Doses Correlate with Reduced Incidence of Relapse and Better Event-Free Survival after KIR-Ligand Mismatch Cord Blood Transplantation for Childhood Acute Myeloid Leukemia

Outcome of Newly Diagnosed Children and Adolescents with Localized Lymphoblastic Lymphoma Treated on JPLSG-LLB-NHL03 Trial: A Report from the Japan Children's Cancer Group

Risk Stratified Therapy with Nelarabine and Intensified Administration of L-Asparaginase for Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia in Adolescents and Young Adults (JPLSG T-11/JALSG T-ALL-211-U): An Intergroup Phase 2 Study

Prognostic Factors in Children with Acute Myeloid Leukemia Receiving the First Hematopoietic Stem Cell Transplantation in Second Remission

Impact of Nelarabine, Intensive L-Asparaginase, and Protracted Intrathecal Therapy on Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia: Results from the Japanese Pediatric Leukemia/Lymphoma Study Group and the Japan Adult Leukemia Study Group

Clonal Evolution Pattern and Prognostic Significance of Clonal Architecture in KMT2A -Rearranged Acute Myeloid Leukemia

Hematopoietic Stem-Cell Transplantation in Children with Refractory Acute Myeloid Leukemia

Hematopoietic Stem Cell Transplantation in Children with Refractory Acute Lymphoblastic Leukemia

Nationwide Survey of Pediatric Hypodiploid Acute Lymphoblastic Leukemia in Japan

Augmented Consolidation Therapy Based on Minimal Residual Disease (MRD) and Analysis of the Measurement of Sequential MRD in Childhood Acute Lymphoblastic Leukemia : Children's Cancer and Leukemia Study Group of JAPAN (CCLSG), Cclsg ALL 2004 Protocol Study

Comparison of transplantation with reduced and myeloablative conditioning for children with acute lymphoblastic leukemia

Comparison of Stem Cell Transplantation with Reduced Intensity Conditioning (RIC) and Myeloablative Conditioning (MAC) for Children with Acute Lymphoblastic Leukemia

Mechanisms and Prevention of Fatal Cardiotoxicity Following High-Dose Cyclophosphamide Therapy

Comparison Of Intravenous With Oral Busulfan In Allogeneic Hematopoietic Stem Cell Transplantation With Myeloablative Conditioning Regimens For Pediatric Acute Leukemia

Myeloperoxidase-Derived Halogenative Stress, a Possible Cause of Benzene Leukemogenesis

Combined Analysis of Treatments for Pediatric T-ALL in KYCCSG Protocols, ALL-96 and ALL-02.

Direct Interaction of G-CSF-Stimulated-Neutrophils and HUVECs Are Necessary for Production of IL-8 in Endothelial Cells.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only